img

Global Freeze-dried Human Rabies Vaccine Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Freeze-dried Human Rabies Vaccine Market Research Report 2024

Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies.
According to Mr Accuracy reports’s new survey, global Freeze-dried Human Rabies Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Freeze-dried Human Rabies Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Freeze-dried Human Rabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sanofi Pasteur SA
Guangzhou Nuocheng
Ningbo Rong'an
Hualan Bio-vaccine
Bharat Biotech
Bavarian Nordic
Serum Institute of India Pvt.
Chengdu Kanghua Biology
Changchun Zhuoyi Biology
Dalian Yali Peak
Segment by Type
Vero Cells
Human Diploid Cells
Other

Segment by Application


Hospital
Clinic

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Freeze-dried Human Rabies Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Freeze-dried Human Rabies Vaccine Market Overview
1.1 Product Overview and Scope of Freeze-dried Human Rabies Vaccine
1.2 Freeze-dried Human Rabies Vaccine Segment by Type
1.2.1 Global Freeze-dried Human Rabies Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Vero Cells
1.2.3 Human Diploid Cells
1.2.4 Other
1.3 Freeze-dried Human Rabies Vaccine Segment by Application
1.3.1 Global Freeze-dried Human Rabies Vaccine Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Freeze-dried Human Rabies Vaccine Market Size Estimates and Forecasts
1.4.1 Global Freeze-dried Human Rabies Vaccine Revenue 2018-2029
1.4.2 Global Freeze-dried Human Rabies Vaccine Sales 2018-2029
1.4.3 Global Freeze-dried Human Rabies Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Freeze-dried Human Rabies Vaccine Market Competition by Manufacturers
2.1 Global Freeze-dried Human Rabies Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Freeze-dried Human Rabies Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Freeze-dried Human Rabies Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Freeze-dried Human Rabies Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Freeze-dried Human Rabies Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Freeze-dried Human Rabies Vaccine, Product Type & Application
2.7 Freeze-dried Human Rabies Vaccine Market Competitive Situation and Trends
2.7.1 Freeze-dried Human Rabies Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Freeze-dried Human Rabies Vaccine Players Market Share by Revenue
2.7.3 Global Freeze-dried Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Freeze-dried Human Rabies Vaccine Retrospective Market Scenario by Region
3.1 Global Freeze-dried Human Rabies Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Freeze-dried Human Rabies Vaccine Global Freeze-dried Human Rabies Vaccine Sales by Region: 2018-2029
3.2.1 Global Freeze-dried Human Rabies Vaccine Sales by Region: 2018-2024
3.2.2 Global Freeze-dried Human Rabies Vaccine Sales by Region: 2024-2029
3.3 Global Freeze-dried Human Rabies Vaccine Global Freeze-dried Human Rabies Vaccine Revenue by Region: 2018-2029
3.3.1 Global Freeze-dried Human Rabies Vaccine Revenue by Region: 2018-2024
3.3.2 Global Freeze-dried Human Rabies Vaccine Revenue by Region: 2024-2029
3.4 North America Freeze-dried Human Rabies Vaccine Market Facts & Figures by Country
3.4.1 North America Freeze-dried Human Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Freeze-dried Human Rabies Vaccine Sales by Country (2018-2029)
3.4.3 North America Freeze-dried Human Rabies Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Freeze-dried Human Rabies Vaccine Market Facts & Figures by Country
3.5.1 Europe Freeze-dried Human Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Freeze-dried Human Rabies Vaccine Sales by Country (2018-2029)
3.5.3 Europe Freeze-dried Human Rabies Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Freeze-dried Human Rabies Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Freeze-dried Human Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Freeze-dried Human Rabies Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Freeze-dried Human Rabies Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Freeze-dried Human Rabies Vaccine Market Facts & Figures by Country
3.7.1 Latin America Freeze-dried Human Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Freeze-dried Human Rabies Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Freeze-dried Human Rabies Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Freeze-dried Human Rabies Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Freeze-dried Human Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Freeze-dried Human Rabies Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Freeze-dried Human Rabies Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Freeze-dried Human Rabies Vaccine Sales by Type (2018-2029)
4.1.1 Global Freeze-dried Human Rabies Vaccine Sales by Type (2018-2024)
4.1.2 Global Freeze-dried Human Rabies Vaccine Sales by Type (2024-2029)
4.1.3 Global Freeze-dried Human Rabies Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Freeze-dried Human Rabies Vaccine Revenue by Type (2018-2029)
4.2.1 Global Freeze-dried Human Rabies Vaccine Revenue by Type (2018-2024)
4.2.2 Global Freeze-dried Human Rabies Vaccine Revenue by Type (2024-2029)
4.2.3 Global Freeze-dried Human Rabies Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Freeze-dried Human Rabies Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Freeze-dried Human Rabies Vaccine Sales by Application (2018-2029)
5.1.1 Global Freeze-dried Human Rabies Vaccine Sales by Application (2018-2024)
5.1.2 Global Freeze-dried Human Rabies Vaccine Sales by Application (2024-2029)
5.1.3 Global Freeze-dried Human Rabies Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Freeze-dried Human Rabies Vaccine Revenue by Application (2018-2029)
5.2.1 Global Freeze-dried Human Rabies Vaccine Revenue by Application (2018-2024)
5.2.2 Global Freeze-dried Human Rabies Vaccine Revenue by Application (2024-2029)
5.2.3 Global Freeze-dried Human Rabies Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Freeze-dried Human Rabies Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi Pasteur SA
6.1.1 Sanofi Pasteur SA Corporation Information
6.1.2 Sanofi Pasteur SA Description and Business Overview
6.1.3 Sanofi Pasteur SA Freeze-dried Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Sanofi Pasteur SA Freeze-dried Human Rabies Vaccine Product Portfolio
6.1.5 Sanofi Pasteur SA Recent Developments/Updates
6.2 Guangzhou Nuocheng
6.2.1 Guangzhou Nuocheng Corporation Information
6.2.2 Guangzhou Nuocheng Description and Business Overview
6.2.3 Guangzhou Nuocheng Freeze-dried Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Guangzhou Nuocheng Freeze-dried Human Rabies Vaccine Product Portfolio
6.2.5 Guangzhou Nuocheng Recent Developments/Updates
6.3 Ningbo Rong'an
6.3.1 Ningbo Rong'an Corporation Information
6.3.2 Ningbo Rong'an Description and Business Overview
6.3.3 Ningbo Rong'an Freeze-dried Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Ningbo Rong'an Freeze-dried Human Rabies Vaccine Product Portfolio
6.3.5 Ningbo Rong'an Recent Developments/Updates
6.4 Hualan Bio-vaccine
6.4.1 Hualan Bio-vaccine Corporation Information
6.4.2 Hualan Bio-vaccine Description and Business Overview
6.4.3 Hualan Bio-vaccine Freeze-dried Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Hualan Bio-vaccine Freeze-dried Human Rabies Vaccine Product Portfolio
6.4.5 Hualan Bio-vaccine Recent Developments/Updates
6.5 Bharat Biotech
6.5.1 Bharat Biotech Corporation Information
6.5.2 Bharat Biotech Description and Business Overview
6.5.3 Bharat Biotech Freeze-dried Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Bharat Biotech Freeze-dried Human Rabies Vaccine Product Portfolio
6.5.5 Bharat Biotech Recent Developments/Updates
6.6 Bavarian Nordic
6.6.1 Bavarian Nordic Corporation Information
6.6.2 Bavarian Nordic Description and Business Overview
6.6.3 Bavarian Nordic Freeze-dried Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Bavarian Nordic Freeze-dried Human Rabies Vaccine Product Portfolio
6.6.5 Bavarian Nordic Recent Developments/Updates
6.7 Serum Institute of India Pvt.
6.6.1 Serum Institute of India Pvt. Corporation Information
6.6.2 Serum Institute of India Pvt. Description and Business Overview
6.6.3 Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine Product Portfolio
6.7.5 Serum Institute of India Pvt. Recent Developments/Updates
6.8 Chengdu Kanghua Biology
6.8.1 Chengdu Kanghua Biology Corporation Information
6.8.2 Chengdu Kanghua Biology Description and Business Overview
6.8.3 Chengdu Kanghua Biology Freeze-dried Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Chengdu Kanghua Biology Freeze-dried Human Rabies Vaccine Product Portfolio
6.8.5 Chengdu Kanghua Biology Recent Developments/Updates
6.9 Changchun Zhuoyi Biology
6.9.1 Changchun Zhuoyi Biology Corporation Information
6.9.2 Changchun Zhuoyi Biology Description and Business Overview
6.9.3 Changchun Zhuoyi Biology Freeze-dried Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Changchun Zhuoyi Biology Freeze-dried Human Rabies Vaccine Product Portfolio
6.9.5 Changchun Zhuoyi Biology Recent Developments/Updates
6.10 Dalian Yali Peak
6.10.1 Dalian Yali Peak Corporation Information
6.10.2 Dalian Yali Peak Description and Business Overview
6.10.3 Dalian Yali Peak Freeze-dried Human Rabies Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Dalian Yali Peak Freeze-dried Human Rabies Vaccine Product Portfolio
6.10.5 Dalian Yali Peak Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Freeze-dried Human Rabies Vaccine Industry Chain Analysis
7.2 Freeze-dried Human Rabies Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Freeze-dried Human Rabies Vaccine Production Mode & Process
7.4 Freeze-dried Human Rabies Vaccine Sales and Marketing
7.4.1 Freeze-dried Human Rabies Vaccine Sales Channels
7.4.2 Freeze-dried Human Rabies Vaccine Distributors
7.5 Freeze-dried Human Rabies Vaccine Customers
8 Freeze-dried Human Rabies Vaccine Market Dynamics
8.1 Freeze-dried Human Rabies Vaccine Industry Trends
8.2 Freeze-dried Human Rabies Vaccine Market Drivers
8.3 Freeze-dried Human Rabies Vaccine Market Challenges
8.4 Freeze-dried Human Rabies Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Freeze-dried Human Rabies Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Freeze-dried Human Rabies Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Freeze-dried Human Rabies Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Freeze-dried Human Rabies Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Freeze-dried Human Rabies Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Freeze-dried Human Rabies Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Freeze-dried Human Rabies Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Freeze-dried Human Rabies Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Freeze-dried Human Rabies Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Freeze-dried Human Rabies Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Freeze-dried Human Rabies Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Freeze-dried Human Rabies Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Freeze-dried Human Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Freeze-dried Human Rabies Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Freeze-dried Human Rabies Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Freeze-dried Human Rabies Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Freeze-dried Human Rabies Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Freeze-dried Human Rabies Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Freeze-dried Human Rabies Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Freeze-dried Human Rabies Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Freeze-dried Human Rabies Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Freeze-dried Human Rabies Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Freeze-dried Human Rabies Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Freeze-dried Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Freeze-dried Human Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Freeze-dried Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Freeze-dried Human Rabies Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Freeze-dried Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Freeze-dried Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Freeze-dried Human Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Freeze-dried Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Freeze-dried Human Rabies Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Freeze-dried Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Freeze-dried Human Rabies Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Freeze-dried Human Rabies Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Freeze-dried Human Rabies Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Freeze-dried Human Rabies Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Freeze-dried Human Rabies Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Freeze-dried Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Freeze-dried Human Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Freeze-dried Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Freeze-dried Human Rabies Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Freeze-dried Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Freeze-dried Human Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Freeze-dried Human Rabies Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Freeze-dried Human Rabies Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Freeze-dried Human Rabies Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Freeze-dried Human Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Freeze-dried Human Rabies Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Freeze-dried Human Rabies Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Freeze-dried Human Rabies Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Freeze-dried Human Rabies Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Freeze-dried Human Rabies Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Freeze-dried Human Rabies Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Freeze-dried Human Rabies Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Freeze-dried Human Rabies Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Freeze-dried Human Rabies Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Freeze-dried Human Rabies Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Freeze-dried Human Rabies Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Freeze-dried Human Rabies Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Freeze-dried Human Rabies Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Freeze-dried Human Rabies Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Freeze-dried Human Rabies Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Freeze-dried Human Rabies Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Freeze-dried Human Rabies Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Freeze-dried Human Rabies Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Freeze-dried Human Rabies Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Freeze-dried Human Rabies Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Sanofi Pasteur SA Corporation Information
Table 71. Sanofi Pasteur SA Description and Business Overview
Table 72. Sanofi Pasteur SA Freeze-dried Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Sanofi Pasteur SA Freeze-dried Human Rabies Vaccine Product
Table 74. Sanofi Pasteur SA Recent Developments/Updates
Table 75. Guangzhou Nuocheng Corporation Information
Table 76. Guangzhou Nuocheng Description and Business Overview
Table 77. Guangzhou Nuocheng Freeze-dried Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Guangzhou Nuocheng Freeze-dried Human Rabies Vaccine Product
Table 79. Guangzhou Nuocheng Recent Developments/Updates
Table 80. Ningbo Rong'an Corporation Information
Table 81. Ningbo Rong'an Description and Business Overview
Table 82. Ningbo Rong'an Freeze-dried Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Ningbo Rong'an Freeze-dried Human Rabies Vaccine Product
Table 84. Ningbo Rong'an Recent Developments/Updates
Table 85. Hualan Bio-vaccine Corporation Information
Table 86. Hualan Bio-vaccine Description and Business Overview
Table 87. Hualan Bio-vaccine Freeze-dried Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Hualan Bio-vaccine Freeze-dried Human Rabies Vaccine Product
Table 89. Hualan Bio-vaccine Recent Developments/Updates
Table 90. Bharat Biotech Corporation Information
Table 91. Bharat Biotech Description and Business Overview
Table 92. Bharat Biotech Freeze-dried Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Bharat Biotech Freeze-dried Human Rabies Vaccine Product
Table 94. Bharat Biotech Recent Developments/Updates
Table 95. Bavarian Nordic Corporation Information
Table 96. Bavarian Nordic Description and Business Overview
Table 97. Bavarian Nordic Freeze-dried Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Bavarian Nordic Freeze-dried Human Rabies Vaccine Product
Table 99. Bavarian Nordic Recent Developments/Updates
Table 100. Serum Institute of India Pvt. Corporation Information
Table 101. Serum Institute of India Pvt. Description and Business Overview
Table 102. Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine Product
Table 104. Serum Institute of India Pvt. Recent Developments/Updates
Table 105. Chengdu Kanghua Biology Corporation Information
Table 106. Chengdu Kanghua Biology Description and Business Overview
Table 107. Chengdu Kanghua Biology Freeze-dried Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Chengdu Kanghua Biology Freeze-dried Human Rabies Vaccine Product
Table 109. Chengdu Kanghua Biology Recent Developments/Updates
Table 110. Changchun Zhuoyi Biology Corporation Information
Table 111. Changchun Zhuoyi Biology Description and Business Overview
Table 112. Changchun Zhuoyi Biology Freeze-dried Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Changchun Zhuoyi Biology Freeze-dried Human Rabies Vaccine Product
Table 114. Changchun Zhuoyi Biology Recent Developments/Updates
Table 115. Dalian Yali Peak Corporation Information
Table 116. Dalian Yali Peak Description and Business Overview
Table 117. Dalian Yali Peak Freeze-dried Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Dalian Yali Peak Freeze-dried Human Rabies Vaccine Product
Table 119. Dalian Yali Peak Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Freeze-dried Human Rabies Vaccine Distributors List
Table 123. Freeze-dried Human Rabies Vaccine Customers List
Table 124. Freeze-dried Human Rabies Vaccine Market Trends
Table 125. Freeze-dried Human Rabies Vaccine Market Drivers
Table 126. Freeze-dried Human Rabies Vaccine Market Challenges
Table 127. Freeze-dried Human Rabies Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Freeze-dried Human Rabies Vaccine
Figure 2. Global Freeze-dried Human Rabies Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Freeze-dried Human Rabies Vaccine Market Share by Type in 2022 & 2029
Figure 4. Vero Cells Product Picture
Figure 5. Human Diploid Cells Product Picture
Figure 6. Other Product Picture
Figure 7. Global Freeze-dried Human Rabies Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Freeze-dried Human Rabies Vaccine Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Freeze-dried Human Rabies Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Freeze-dried Human Rabies Vaccine Market Size (2018-2029) & (US$ Million)
Figure 13. Global Freeze-dried Human Rabies Vaccine Sales (2018-2029) & (K Units)
Figure 14. Global Freeze-dried Human Rabies Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 15. Freeze-dried Human Rabies Vaccine Report Years Considered
Figure 16. Freeze-dried Human Rabies Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global Freeze-dried Human Rabies Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Freeze-dried Human Rabies Vaccine Players: Market Share by Revenue in 2022
Figure 19. Freeze-dried Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Freeze-dried Human Rabies Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Freeze-dried Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 22. North America Freeze-dried Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 23. United States Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Freeze-dried Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 26. Europe Freeze-dried Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. Germany Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Freeze-dried Human Rabies Vaccine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Freeze-dried Human Rabies Vaccine Revenue Market Share by Region (2018-2029)
Figure 34. China Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Freeze-dried Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 42. Latin America Freeze-dried Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Freeze-dried Human Rabies Vaccine Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Freeze-dried Human Rabies Vaccine Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Freeze-dried Human Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Freeze-dried Human Rabies Vaccine by Type (2018-2029)
Figure 52. Global Revenue Market Share of Freeze-dried Human Rabies Vaccine by Type (2018-2029)
Figure 53. Global Freeze-dried Human Rabies Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Freeze-dried Human Rabies Vaccine by Application (2018-2029)
Figure 55. Global Revenue Market Share of Freeze-dried Human Rabies Vaccine by Application (2018-2029)
Figure 56. Global Freeze-dried Human Rabies Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 57. Freeze-dried Human Rabies Vaccine Value Chain
Figure 58. Freeze-dried Human Rabies Vaccine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries